Key result
Intravenous ANP increased heart rate dose-dependently, which was abolished by propranolol, whereas ANP-induced lipid mobilization and glycolysis were not suppressed by beta-adrenergic blockade.
Why the study?
Does beta-adrenergic blockade with propranolol alter the cardiovascular and metabolic effects of atrial natriuretic peptide in healthy young males?
Does beta-adrenergic blockade with propranolol alter the cardiovascular and metabolic effects of atrial natriuretic peptide in healthy young males?
Cardiovascular effects of ANP are partly mediated by beta-adrenergic receptors, while its metabolic effects on lipid mobilization and glycolysis operate through independent mechanisms.
Propranolol may blunt ANP chronotropy without affecting lipid mobilization or glycolysis; leaves open translation to patients with cardiovascular disease.
CONTEXT: Atrial natriuretic peptide (ANP) has well-known cardiovascular effects and modifies lipid and carbohydrate metabolism in humans. OBJECTIVE: The objective of the study was to determine the metabolic and cardiovascular interaction of beta-adrenergic receptors and ANP. DESIGN: This was a crossover study, conducted 2004-2005. SETTING: The study was conducted at an academic clinical research center. PATIENTS: PATIENTS included 10 healthy young male subjects (body mass index 24 +/- 1 kg/m2). INTERVENTION: We infused iv incremental ANP doses (6.25, 12.5, and 25 ng/kg.min) with and without propranolol (0.20 mg/kg in divided doses followed by 0.033 mg/kg.h infusion). Metabolism was monitored through venous blood sampling, im, and sc microdialysis and indirect calorimetry. Cardiovascular changes were monitored by continuous electrocardiogram and beat-by-beat blood pressure recordings. MAIN OUTCOME MEASURES: Venous nonesterified fatty acid, glycerol, glucose, and insulin; and microdialysate glucose, glycerol, lactate, and pyruvate were measured. RESULTS: ANP increased heart rate dose dependently. beta-Adrenergic receptor blockade abolished the response. ANP elicited a dose-dependent increase in serum nonesterified fatty acid and glycerol concentrations. The response was not suppressed with propranolol. Venous glucose and insulin concentrations increased with ANP, both without or with propranolol. ANP induced lipid mobilization in sc adipose tissue. In skeletal muscle, microdialysate lactate increased, whereas the lactate to pyruvate ratio decreased, both with and without propranolol. Higher ANP doses increased lipid oxidation, whereas energy expenditure remained unchanged. Propranolol tended to attenuate the increase in lipid oxidation. CONCLUSIONS: Selected cardiovascular ANP effects are at least partly mediated by beta-adrenergic receptor stimulation. ANP-induced changes in lipid mobilization and glycolysis are mediated by another mechanism, presumably stimulation of natriuretic peptide receptors, whereas substrate oxidation might be modulated through adrenergic mechanisms.
No takes yet. Share an insight, caveat, or question.
Birkenfeld et al. (2006) studied Healthy (n=10). Atrial natriuretic peptide (ANP) with propranolol vs. ANP without propranolol was evaluated on Venous nonesterified fatty acid, glycerol, glucose, and insulin; and microdialysate glucose, glycerol, lactate, and pyruvate. Intravenous ANP increased heart rate dose-dependently, which was abolished by propranolol, whereas ANP-induced lipid mobilization and glycolysis were not suppressed by beta-adrenergic blockade.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: